
    
      The duration of the study will be of 120 weeks: 24 for recruitment and 96 weeks of follow-up.
      The reasons for the study duration of 2 years is that, up to now, doravirine has not been
      studied in 2 or 3 classes multi-drug-resistance (MDR) and thus, demonstration of durability
      of effect over a prolonged period of time is as important as the short-term efficacy.
    
  